Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD80 is a membrane-bound glycoprotein expressed on antigen-presenting cells (APCs) that plays a crucial role in T-cell activation and immune regulation. It interacts with CD28 to provide costimulatory signals for T-cell activation and with CTLA-4 to deliver inhibitory signals, thus modulating the balance between immune stimulation and tolerance. Recent studies show cis-interactions between PD-L1 and CD80 modulate both PD-L1/PD-1 signaling and CTLA-4 binding dynamics.
Modulates T-cell activation by binding to CD28 (costimulation) or CTLA-4 (inhibition); also interacts with PD-L1 to modulate PD-1/PD-L1 and CTLA-4 signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD80 antigen (CD80).